4:08 PM ET
8-K
Business Update
Annovis Bio Business Update
Annovis Bio provided a preliminary estimate of its cash and cash equivalents, which were approximately $2.8 million as of September 30, 2026. The company noted that it has not yet completed its quarterly financial closing processes and the figure is subject to change upon completion of its full interim financial statements.